Drugs / Tetanus human immunoglobulin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06360250 Comparator | Apr → Oct 2024 | tetanus | Changchun BCHT Biotechnology Co. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus human immunoglobulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06360250 ↗ |
| Known as | HTIG | “Tetanus human immunoglobulin (HTIG)” NCT06360250 ↗ |
| Modality | Protein / enzyme biologic | “Tetanus human immunoglobulin (HTIG)” NCT06360250 ↗ |